The arritmiólogos closed its annual meeting Recalling that each year die 40,000 Spaniards from sudden death.

-Closed in A Coruña the eleventh meeting of the section of electrophysiology and arrhythmias from the society Spanish of Cardiology (SEC) which has been assisted by 650 experts

-experts have sought stress the importance of knowing in time to respond to a cardiacfor every 20 seconds occurs in Spain and only 10% of the population knows to perform resuscitation techniques

– during the meeting, the new anticoagulants have also been one of the topics. Thus the benefits that will bring the next approval of rivaroxaban versus current anticoagulants have been discussed. Easy administration, to deal with a single dose, and the minor associated kidney complications are some of them

-the economic crisis has been present during the meeting, as it has been announced that, although Spain has very high level as regards Europe arritmiólogos, the number of specialists by Centre is half that of their European counterparts

-precisely, Pharmacoeconomics and health economics will be the new subjects to be dealt with at the meeting of next year it will take place from 17 to 19 April in Santander

to Coruña, may 2012.- the Spanish Cardiology Society (SEC) closed the XI meeting of the section of electrophysiology and arrhythmias, which was held in A Coruña, recalling that in Spain are 40,000 people that die each year as a result of sudden death.

Every 20 seconds occurs a cardiac Spain, so know quickly bring relief to the person who suffers is essential to revive her. For this reason, experts wanted to insist during the meeting on the importance of knowing the techniques of cardiopulmonary resuscitation, in Spain, only 10% of the population know perform them.

Over the three days that was developed, experts have addressed topics related to arrhythmias, cardiovascular disease which consist of a disruption of normal heart rhythm. Main symptoms include palpitations, dizziness, syncope, chest pain or fatigue.

So the treatment by anticoagulants has been one of the aspects discussed by experts, which have highlighted the advantages of the new oral anticoagulants (dabigatrán the only one authorized in Spain, rivaroxaban, whose approval is expected in the coming weeks; and apixaban, a little behind in time), from the classics (Sintrom): the first advantage is that they allow to simplify the life of the patient, because you don’t need to adjust doses, avoid you numerous analytical as well as go to Hematology units and various health checks; and the second is that they are more effective in certain subgroups of patients.

The economic crisis has also been present during the meeting, as it has been announced that, although the Spanish arritmiólogos which get better grades in the European tests, not they can attend to all patients as the number of specialists by Centre is half that of their European counterparts (2.5 face 5).

Dr. Ignacio Fernández Lozano, President of the section of electrophysiology and arrhythmias, valued aspect of the crisis as necessary to address in the coming years, theme as a result of the economic crisis we are experiencing in these moments and the numerous announcements of cuts in health, it is very necessary that add any session on Pharmacoeconomics and health economy in the next Congress, and that it is our responsibility that patients are well cared for, by those who will have to find solutions to the economic problems ”. The next meeting of the section will take place from 17 to 19 April in Santander

as assessment of the meeting, Dr. Fernández Lozano, this is already the Eleventh Edition and little by little we we realize that this meeting is more than just a meeting of the section of the SEC, is the Congress of arrhythmias ”.

Spanish society of Cardiology (SEC)

The Spanish society of Cardiology (SEC) is a scientific and professional organization non-profit dedicated to increasing the State of knowledge about the heart and circulatory system, advance the prevention and treatment of their diseases and to improve survival and quality of life for heart patients.

Además, la SEC tiene entre sus objetivos principales contribuir a la investigación internacional, especialmente europea y latinoamericana, crear vínculos nacionales e internacionales para el desarrollo de acciones, y representar a todos los profesionales interesados en el área de la cardiología.